MicroRNAs in drug addiction: Current status and future perspectives

被引:13
|
作者
Zhao, Yue [1 ,2 ,3 ]
Qin, Feng [1 ,2 ,3 ]
Han, Shuang [1 ,2 ,3 ]
Li, Shu [1 ,2 ,3 ]
Zhao, Ying [1 ,2 ,3 ]
Wang, Hongbo [4 ]
Tian, Jingwei [4 ]
Cen, Xiaobo [1 ,2 ,3 ]
机构
[1] Sichuan Univ, Natl Chengdu Ctr Safety Evaluat Drugs, West China Hosp, State Key Lab Biotherapy, Keyuan Rd 4,Gaopeng St, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Canc Ctr, West China Hosp, Keyuan Rd 4,Gaopeng St, Chengdu 610041, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China
[4] Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Minist Educ, Yantai 264005, Peoples R China
基金
中国国家自然科学基金;
关键词
microRNAs (miRNAs); Drug addiction; Neuroadaptation; Biomarker; MU-OPIOID RECEPTOR; MEDIATED DOWN-REGULATION; POSTTRANSCRIPTIONAL REGULATION; ALCOHOL EXPOSURE; BDNF EXPRESSION; GABAERGIC NEUROTRANSMISSION; GLUCOCORTICOID-RECEPTOR; EXTRACELLULAR VESICLES; ALZHEIMERS-DISEASE; ADULT NEUROGENESIS;
D O I
10.1016/j.pharmthera.2022.108215
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug addiction is a chronic and relapsing brain disorder characterized by compulsive drug seeking and continued drug use despite adverse consequences. The high prevalence and social burden of addiction is indisputable; however, the available intervention is insufficient. Abnormal gene expression is observed in reward-related brain regions in animal models of addiction. The modulation of gene expression and aberrant adaptation of neural networks attribute to the changes in brain function under repeated exposure to addictive drugs. The emerging recognition of the role of microRNA (miRNA) provides new insights into many biological and pathological processes in the central nervous system. Considerable studies have demonstrated that miRNAs are strong modulators of posttranscriptional gene expression in drug addiction. Here, we provide an overview of miRNAs, followed by evidence for aberrant miRNA expression and regulatory roles of miRNAs in drug addiction as well as neuroadaptation. We concluded by providing our perspectives that miRNAs have the potential as novel therapeutic targets for drug addiction. (c) 2022 Published by Elsevier Inc.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] MicroRNAs of parasites: current status and future perspectives
    Liu, Quan
    Tuo, Wenbin
    Gao, Hongwei
    Zhu, Xing-Quan
    PARASITOLOGY RESEARCH, 2010, 107 (03) : 501 - 507
  • [2] MicroRNAs of parasites: current status and future perspectives
    Quan Liu
    Wenbin Tuo
    Hongwei Gao
    Xing-Quan Zhu
    Parasitology Research, 2010, 107 : 501 - 507
  • [3] Current Status and Future Perspectives on MRNA Drug Manufacturing
    Webb, Cameron
    Ip, Shell
    Bathula, Nuthan, V
    Popova, Petya
    Soriano, Shekinah K., V
    Ly, Han Han
    Eryilmaz, Burcu
    Viet Anh Nguyen Huu
    Broadhead, Richard
    Rabel, Martin
    Villamagna, Ian
    Abraham, Suraj
    Raeesi, Vahid
    Thomas, Anitha
    Clarke, Samuel
    Ramsay, Euan C.
    Perrie, Yvonne
    Blakney, Anna K.
    MOLECULAR PHARMACEUTICS, 2022, 19 (04) : 1047 - 1058
  • [4] Antibody-drug conjugates: Current status and future perspectives
    Gebleux, Remy
    Casi, Giulio
    PHARMACOLOGY & THERAPEUTICS, 2016, 167 : 48 - 59
  • [5] Biological research on drug abuse and addiction in Hispanics: Current status and future directions
    Trujillo, Keith A.
    Castaneda, Edward
    Martinez, Diana
    Gonzalez, Gerardo
    DRUG AND ALCOHOL DEPENDENCE, 2006, 84 : S17 - S28
  • [6] Treatment of love addiction: Current status and perspectives
    Sanches, M.
    John, V. P.
    EUROPEAN JOURNAL OF PSYCHIATRY, 2019, 33 (01): : 38 - 44
  • [7] Role of Pharmacogenomics in Antiepileptic Drug Therapy: Current Status and Future Perspectives
    Gambardella, Antonio
    Labate, Angelo
    Mumoli, Laura
    Lopes-Cendes, Iscia
    Cendes, Fernando
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (37) : 5760 - 5765
  • [8] MicroRNAs and Drug Addiction
    Kenny, Paul
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S60 - S61
  • [9] Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics
    Choi Y.H.
    Han H.-K.
    Journal of Pharmaceutical Investigation, 2018, 48 (1) : 43 - 60
  • [10] Current Status and Future Perspectives on Old Drug Repurposing for Cancer Treatment
    Dou, Q. Ping
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2021, 16 (02) : 120 - 121